OmniAb (OABI) Amortization - Intangibles (2022 - 2026)
OmniAb (OABI) reported Amortization - Intangibles of $6.0 million for Q1 2026, up 85.87% year-over-year from $3.2 million in Q1 2025, and up 86.8% quarter-over-quarter from $3.2 million in Q4 2025.
OmniAb (OABI) Amortization - Intangibles (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Amortization - Intangibles data on file, last reported at $6.0 million in Q1 2026.
- Amortization - Intangibles for Q1 2026 came in at $6.0 million, up 85.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.6 million (down 9.61% YoY), and the FY2025 annual result was $12.9 million, down 25.82% from the prior year.
- Amortization - Intangibles advanced to $6.0 million in Q1 2026 per OABI's latest filing, from $3.2 million in the prior quarter.
- Over five years, Amortization - Intangibles peaked at $6.1 million in Q4 2024 and troughed at $3.1 million in Q2 2022.
- A 5-year average of $3.7 million and a median of $3.4 million in 2024 frame the typical range for Amortization - Intangibles.
- The sharpest annual moves came in 2025 and 2026: Amortization - Intangibles sank 47.4% in 2025, then surged 85.87% in 2026.
- A 5-year view of Amortization - Intangibles shows it stood at $3.2 million in 2022, then climbed by 6.47% to $3.4 million in 2023, then surged by 79.25% to $6.1 million in 2024, then slumped by 47.4% to $3.2 million in 2025, then soared by 86.8% to $6.0 million in 2026.
- Business Quant data shows OABI's Amortization - Intangibles at $6.0 million in Q1 2026, $3.2 million in Q4 2025, and $3.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 3.21 Mn |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 3.23 Mn |
| Dec 31, 2024 | 6.11 Mn |
| Sep 30, 2024 | 3.39 Mn |
| Jun 30, 2024 | 4.54 Mn |
| Mar 31, 2024 | 3.40 Mn |
| Dec 31, 2023 | 3.41 Mn |
| Sep 30, 2023 | 3.40 Mn |
| Jun 30, 2023 | 3.38 Mn |
| Mar 31, 2023 | 3.40 Mn |
| Dec 31, 2022 | 3.20 Mn |
| Sep 30, 2022 | 3.26 Mn |
| Jun 30, 2022 | 3.11 Mn |
| Mar 31, 2022 | 3.40 Mn |